"Peptide Fragments" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
Descriptor ID |
D010446
|
MeSH Number(s) |
D12.644.541
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peptide Fragments".
Below are MeSH descriptors whose meaning is more specific than "Peptide Fragments".
This graph shows the total number of publications written about "Peptide Fragments" by people in this website by year, and whether "Peptide Fragments" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 7 | 9 | 16 |
1995 | 7 | 7 | 14 |
1996 | 11 | 7 | 18 |
1997 | 3 | 13 | 16 |
1998 | 13 | 13 | 26 |
1999 | 7 | 20 | 27 |
2000 | 11 | 20 | 31 |
2001 | 11 | 5 | 16 |
2002 | 15 | 14 | 29 |
2003 | 22 | 20 | 42 |
2004 | 11 | 25 | 36 |
2005 | 15 | 23 | 38 |
2006 | 11 | 15 | 26 |
2007 | 15 | 15 | 30 |
2008 | 7 | 11 | 18 |
2009 | 10 | 11 | 21 |
2010 | 10 | 11 | 21 |
2011 | 19 | 14 | 33 |
2012 | 11 | 14 | 25 |
2013 | 15 | 16 | 31 |
2014 | 17 | 13 | 30 |
2015 | 10 | 16 | 26 |
2016 | 15 | 10 | 25 |
2017 | 13 | 15 | 28 |
2018 | 10 | 7 | 17 |
2019 | 13 | 9 | 22 |
2020 | 11 | 6 | 17 |
2021 | 10 | 11 | 21 |
2022 | 0 | 7 | 7 |
2023 | 1 | 9 | 10 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peptide Fragments" by people in Profiles.
-
Bivalirudin Stability in Citrated Plasma and Citrated Whole Blood. Arch Pathol Lab Med. 2024 Jan 01; 148(1):11-12.
-
Angiotensin 1-7 exerts antioxidant effects, suppresses Mammalian Target of Rapamycin (mTOR) signaling, and inhibits apoptosis in renal proximal tubular cells. Peptides. 2024 Feb; 172:171136.
-
Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2023 11 09; 30(16):1731-1740.
-
Diagnostic Accuracy of Urinary N Terminal pro-B Type Natriuretic Peptides for Hemodynamically Significant-Patent Ductus Arteriosus in Preterm Infants. Neonatology. 2024; 121(1):1-6.
-
Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC. Eur J Heart Fail. 2023 11; 25(11):1891-1898.
-
Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Cardiol. 2023 10 01; 204:295-301.
-
Biomarker guided management of hypertension. Curr Opin Nephrol Hypertens. 2023 09 01; 32(5):427-433.
-
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ. Cancer Prev Res (Phila). 2023 06 01; 16(6):333-341.
-
Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol. 2023 03 01; 8(3):222-230.
-
Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study. JACC Heart Fail. 2023 04; 11(4):440-450.